Headline March 17, 2016/ ''' *GREAT HUMANS*..... ..&........GREAT GENES '''

''' *GREAT HUMANS*..... ..&........

GREAT GENES '''

!THE HONOURS OF HONOURS!     -*The International Governance Committee* of !WOW!  -the World Students Society, shall comprise of two types of members:

*The Life Long Members* and  *The Tenured Members*. And in this complex and exalted exercise, many distinguished and sterling  names come highly and passionately recommended:

From America : President Bill Clinton, Melinda Gates, Marissa Myers/Yahoo, Eric Schmidt/Google, Dr. M Jawaid Khan/University of California, Technologist, Amin Malik/Chicago, Farid Zakaria/Newsweek, John Chambers/CISCO, Dr. Andy Groove/Intel, Arianna Huffington.

From Kingdom of Saudi Arabia, Prince Al-Waleed bin Talal, Sheikh Abdul Wahab Saleh Bougary/Mecca, Technologist Ziyad Hejazi, Petromin, Jeddah.

From India : Ms Sonia Ghandhi, Cheetan Bhaggat, Sunil Gavasker.

From Pakistan : Sultan Abassi, Architect Saima Rasool, Maryam Nawaz Sharif, Asifa Zardari Bhutto, Shazia Gul, O''Captain Imran Khan, Asad Umer, Saqib Naveed/MAJU  Lawyer Zulfiqar Abbas Naqvi, Engineer Imran Basit, Dr. Masood Reza, Dr Iftikhar A Khan, Kamran Khan, Hamid Mir, Ms Amina Fahim,  Arshad Sharif, Dr. Sania Saqib. 

M Fahim Khan/Erickson, Engineer Shahid Shakoor, Dr Imran Bokhari, Lawyer Samad Khurram/Harvard, Zaheer Khan/Berkeley,Haider Naqvi, Engineer Basharat Akber Khan, Qazi Ahmed Khan, Qazi Rashid Manzoor/ICI,  Naveed Iqbal Querishi/Siemens, Saqib Kiyani/Warwick University.

From Belgium : Banker Malik Ali Nawaz/University of Cambridge.

From Austria : Ms. Kadija Javed Khan/Harvard University.

From UK : M Hamad Khan/University of Reading.

From Ireland : Chartered Accountant Imran Khan/University of Trinity and Lawyer Zainab Khan/King's College         

From Bangladesh : Former Air Chief Marshal Fakhr-ul-Azam.

From Australia : Dr Siraj Ul Haq Querishi, Engineer Nasir Khan........and now to the research.......

A recombinant DNA, disaster could be especially severe for workers employed in the industries using the technique. 

The Oil, Chemical and Atomic Workers International  Union has expressed worry that recombinant DNA is one more hazard to workers among whom asbestos, dyes, pesticides and synthetic hormones have already induced a high incidence of health problems.

The National Institutes of Health [NIH], which funds a large portion of recombinant DNA work, has established a watchdog committee, to monitor safety, and forbids certain experiments.

But 80 to 85 percent of current work is conducted in everyday labs where workers come and go, and where safety precautions are minimal. Only a few experiments   -like transplanting genes that involve viral products of toxins  -are conducted in especially equipped rooms.  

 
The Promise. Still, most scientists believe that seven years of recombinant DNA research   -and decades of work with conventional research techniques  -have proved that risks are low.

''The pharmaceutical industry has been making all kinds of stuff, including vaccines for yellow fever, typhoid and diphtheria, and they have a good safety record,'' says Stanley Falkow, Stanford microbiologist.

With the staggering possibilities for human engineering, a majority within the scientific community seem to feel that the potential benefits outweigh the risks.

For example, scientists are confident that recombinant DNA will bring human-gene transplantation within the next few years.

In 1979. W. French Anderson, and colleagues at the NIH and Rockefeller University used recombinant DNA to inject the gene responsible for the production of human hemoglobin into mouse-tissue cultures.

Early in 1980, after the mouse cells had replicated themselves millions of times, human hemoglobin gene  was still present and partially functional.

The nest step will be to inject a normally functioning hemoglobin gene into a live, anemic mouse to see if the gene  ''takes'' and helps the mouse survive its anemia. 

Anderson believes that genetic injections in human beings who also have anemia problems rooted in gene function disorders are also ultimately within reach.    

Human transplants are but one promising application of recombinant DNA technology. Through it, science is also gaining a deeper understanding of the body's profound secrets and the secrets of diseases  -including perhaps, cancer.

''Some people believe that cancer is the result of abnormal gene expression,'' says Michael Harpold of the University of Southern California/Los Angeles County Comprehensive Cancer Center.

''But that is only a hypothesis because we don't understand the nature of normal gene expression. 

With a recombinant DNA we can look for the principles of how different concerns express themselves. And then perhaps derive ways to prevent those mechanisms from being activated.''

Not since atomic fission has a new science brought mankind such a challenging spectrum of risk and promise. 

With respectful dedication to the Students, Professors and Teachers of the world. See Ya all on !WOW!   -the World Students Society and the Ecosystem 2011:

''' Points To Ponder '''

Good Night and God Bless

SAM Daily Times - the Voice of the Voiceless